pI: 7.1008 |
Length (AA): 493 |
MW (Da): 53097 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127302)
Species | Accession | Gene Product |
---|---|---|
Candida albicans | CaO19.2281 | 3-oxoacid CoA-transferase |
Candida albicans | CaO19.9821 | 3-oxoacid CoA-transferase |
Caenorhabditis elegans | CELE_C05C10.3 | Protein C05C10.3 |
Dictyostelium discoideum | DDB_G0288105 | 3-oxoacid CoA-transferase |
Drosophila melanogaster | Dmel_CG1140 | Succinyl-CoA:3-ketoacid CoA transferase |
Escherichia coli | b1694 | putative acetyl-CoA:acetoacetyl-CoA transferase: alpha subunit/beta subunit |
Escherichia coli | b2222 | acetyl-CoA:acetoacetyl-CoA transferase, beta subunit |
Escherichia coli | b2221 | acetyl-CoA:acetoacetyl-CoA transferase, alpha subunit |
Homo sapiens | ENSG00000083720 | 3-oxoacid CoA transferase 1 |
Homo sapiens | ENSG00000198754 | 3-oxoacid CoA transferase 2 |
Leishmania braziliensis | LbrM.30.1810 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania braziliensis | LbrM.33.2630 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Leishmania donovani | LdBPK_332470.1 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Leishmania infantum | LinJ.30.1910 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania infantum | LinJ.33.2470 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Leishmania infantum | LinJ.30.1920 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania major | LmjF.30.1930 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania major | LmjF.33.2340 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Leishmania major | LmjF.30.1940 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania mexicana | LmxM.29.1940 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Leishmania mexicana | LmxM.32.2340 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Leishmania mexicana | LmxM.29.1930 | succinyl-coa:3-ketoacid-coenzyme a transferase- like protein |
Mus musculus | ENSMUSG00000022186 | 3-oxoacid CoA transferase 1 |
Mus musculus | ENSMUSG00000076436 | 3-oxoacid CoA transferase 2A |
Mus musculus | ENSMUSG00000076438 | 3-oxoacid CoA transferase 2B |
Mycobacterium tuberculosis | Rv3551 | Possible CoA-transferase (alpha subunit) |
Mycobacterium tuberculosis | Rv2503c | Probable succinyl-CoA:3-ketoacid-coenzyme A transferase (beta subunit) ScoB (3-oxo-acid:CoA transferase) (OXCT B) (succinyl CoA: |
Mycobacterium tuberculosis | Rv2504c | Probable succinyl-CoA:3-ketoacid-coenzyme A transferase (alpha subunit) ScoA (3-oxo acid:CoA transferase) (OXCT A) (succinyl-CoA |
Mycobacterium ulcerans | MUL_4114 | CoA-transferase subunit alpha |
Mycobacterium ulcerans | MUL_3781 | succinyl-CoA:3-ketoacid-coenzyme a transferase (beta subunit) ScoB |
Mycobacterium ulcerans | MUL_3782 | succinyl-CoA:3-ketoacid-coenzyme a transferase (alpha subunit) ScoA |
Schmidtea mediterranea | mk4.014458.01 | |
Schmidtea mediterranea | mk4.003316.01 | |
Schmidtea mediterranea | mk4.013488.00 | Probable succinyl-CoA:3-ketoacid coenzyme A transferase, mitochondrial |
Schmidtea mediterranea | mk4.047668.00 | Probable succinyl-CoA:3-ketoacid coenzyme A transferase, mitochondrial |
Schmidtea mediterranea | mk4.028415.00 | |
Schmidtea mediterranea | mk4.013488.01 | |
Schmidtea mediterranea | mk4.044417.01 | Probable succinyl-CoA:3-ketoacid coenzyme A transferase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.11.2980 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Trypanosoma brucei | Tb927.11.2690 | Succinyl-CoA:3-ketoacid coenzyme A transferase, mitochondrial |
Trypanosoma congolense | TcIL3000_0_54130 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Trypanosoma congolense | TcIL3000.11.2430 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.506301.50 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Trypanosoma cruzi | TcCLB.504153.360 | succinyl-coA:3-ketoacid-coenzyme A transferase, mitochondrial precursor, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2546 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb11.02.0290 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0290 this record | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0290 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.0290 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1694 | Escherichia coli | non-essential | goodall |
b2221 | Escherichia coli | non-essential | goodall |
b2222 | Escherichia coli | non-essential | goodall |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 3 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.2
Target | Type | Source | Notes |
---|---|---|---|
Tb927.11.2690 | cloned gene | BRENDA | A gene with this EC number or name or sequence has been cloned from Trypanosoma brucei ( 1 ) |
1 literature reference was collected for this gene.